Middle Molecule IT-based Drug Discovery Laboratory (MIDL)
Development of a middle molecule drug discovery platform that utilizes computer science
| The Middle Molecule IT-based Drug Discovery Laboratory (MIDL) was established in September of 2017 as one of the “Innovation Research Initiatives” at Tokyo Institute of Technology. We are pioneering new middle molecule simulation technologies and design methods and are proceeding with their on-site applications for middle molecule drug discovery in close collaboration between researchers for computation and experiments. In addition, by combining information technology with advanced technologies for peptide and nucleic acid synthesis the Institute owns, we aim to put them into practical use in middle molecule drug discovery. |
 |